Different roles of proteolipids and 70-kDa subunits of V-ATPase in growth and death of cultured human cells

Genes to Cells : Devoted to Molecular & Cellular Mechanisms
Hong ZhanShoji Ohkuma

Abstract

The vacuolar-type proton-translocating adenosine triphosphatase (V-ATPase) plays important roles in cell growth and tumour progression. V-ATPase is composed of two distinct structures, a hydrophilic catalytic cytosolic sector (V(1)) and a hydrophobic transmembrane sector (V(0)). The V(1) sector is composed of 5-8 different subunits with the structure A(3)B(3)C(1)D(1)E(1)F(1)G(1)H(1). The V0 sector is composed of 5 different subunits with the structure 1161381191166. The over-expression of 16-kDa proteolipid subunit of V-ATPase in the perinuclear region of the human adventitial fibroblasts promotes phenotypic modulation that contributes to neointimal formation and medial thickening. A relationship between oncogenicity and the expression of the 16-kDa proteolipid has also been suggested in human pancreatic carcinoma tissue. We found that the mRNA levels of the 16-kDa proteolipid but not of the 70-kDa subunit of V-ATPase in human myofibroblasts were more abundant in serum-containing medium (MF(+) cells) than serum-free medium (MF(-) cells). In HeLa cells, the levels of mRNA and protein of the 16-kDa, 21-kDa or 70-kDa were clearly suppressed when the corresponding anti-sense oligonucleotides were administered to the culture medium....Continue Reading

References

Oct 28, 1992·Annals of the New York Academy of Sciences·L L Thomas, C M Price
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G A GillespieS T Reeders
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·T NoumiN Nelson
May 15, 1991·Biochemical and Biophysical Research Communications·H HanadaM Futai
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H Nelson, N Nelson
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M MandelN Nelson
Aug 1, 1993·Pflügers Archiv : European journal of physiology·R EckertD F Hülser
Jun 30, 1995·The Journal of Biological Chemistry·J ZhangM Forgac
Nov 1, 1993·In Vitro Cellular & Developmental Biology. Animal·S OhkumaH Tamura
Oct 1, 1993·The American Journal of Physiology·R Martinez-ZaguilanR J Gillies
Oct 31, 1998·International Journal of Cancer. Journal International Du Cancer·Y Omori, H Yamasaki
May 1, 1999·The Journal of Biological Chemistry·M Forgac
Aug 10, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·H WieczorekW R Harvey
Jan 15, 2000·Advances in Experimental Medicine and Biology·R Bruzzone, C Giaume
Mar 14, 2000·FEBS Letters·P M Kane
Jun 10, 2000·The Journal of Biological Chemistry·T Oka, M Futai
Feb 12, 2002·Nature Reviews. Molecular Cell Biology·Tsuyoshi Nishi, Michael Forgac

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.